Monday, August 12, 2013 10:55:09 AM
Seanf812, They are in Malaysia, behind a private Hong Kong registrar registered URL and hosted by kuih.my in Malaysia.
Well that or the Canary Islands its all sunny, isn't it!
This is the full PPHM article of August 2012 during the run-up to the September 7th events.
Full 10 page PPHM PDF
They have no names, phone, or what so ever and Yang Yu cannot be traced - under that name :) The URL is NOT registered as Apsara Biotech (can not disclose as Honk Kong registrar tries to keep it private - and I don't want to shock anybody to death here :)
Of course we know now how wrong Yang Yu :) was about PPHM's NSCLC.
On Seeking Alpha, this so said professional company publishes anonymously about PPHM. How telling is that. On there own web-site they are almost invisible to themselves Apsara Biotech yet someone produced 10 pages, including graphics and a going back to the PPHM Travastin era. A document that would take me a considerable effort if I had to research and write it!
But it gets even better. For those who follow biopharm's and Eyebuystox research posts:
4 of their next 5 articles are about a company called Alnylam. Alnylam is the company that bought the RNAi patents from Satish Chandran's old company, Nucleonics.
source: sharp observation by EBS on this page.
Well that or the Canary Islands its all sunny, isn't it!
This is the full PPHM article of August 2012 during the run-up to the September 7th events.
Full 10 page PPHM PDF
They have no names, phone, or what so ever and Yang Yu cannot be traced - under that name :) The URL is NOT registered as Apsara Biotech (can not disclose as Honk Kong registrar tries to keep it private - and I don't want to shock anybody to death here :)
Of course we know now how wrong Yang Yu :) was about PPHM's NSCLC.
On Seeking Alpha, this so said professional company publishes anonymously about PPHM. How telling is that. On there own web-site they are almost invisible to themselves Apsara Biotech yet someone produced 10 pages, including graphics and a going back to the PPHM Travastin era. A document that would take me a considerable effort if I had to research and write it!
But it gets even better. For those who follow biopharm's and Eyebuystox research posts:
4 of their next 5 articles are about a company called Alnylam. Alnylam is the company that bought the RNAi patents from Satish Chandran's old company, Nucleonics.
source: sharp observation by EBS on this page.
Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.
